Cargando…
Phenotype prediction for mucopolysaccharidosis type I by in silico analysis
BACKGROUND: Mucopolysaccharidosis type I (MPS I) is an autosomal recessive disease due to deficiency of α-L-iduronidase (IDUA), a lysosomal enzyme that degrades glycosaminoglycans (GAG) heparan and dermatan sulfate. To achieve optimal clinical outcomes, early and proper treatment is essential, which...
Autores principales: | Ou, Li, Przybilla, Michael J., Whitley, Chester B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496269/ https://www.ncbi.nlm.nih.gov/pubmed/28676128 http://dx.doi.org/10.1186/s13023-017-0678-1 |
Ejemplares similares
-
Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I
por: Ou, Li, et al.
Publicado: (2016) -
Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I
por: Lund, Troy C., et al.
Publicado: (2020) -
Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry
por: Clarke, Lorne A., et al.
Publicado: (2019) -
Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI
por: Ahmed, Alia, et al.
Publicado: (2016) -
The neurobehavioral phenotype in mucopolysaccharidosis Type IIIB: An exploratory study
por: Shapiro, E., et al.
Publicado: (2016)